These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17929269)
41. Role of fibulin-3 in lung cancer: in vivo and in vitro analyses. Xu S; Yang Y; Sun YB; Wang HY; Sun CB; Zhang X Oncol Rep; 2014 Jan; 31(1):79-86. PubMed ID: 24142183 [TBL] [Abstract][Full Text] [Related]
42. Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases γ-radiation-induced sensitivity in some pancreatic cancer cell lines. Kim IG; Lee JH; Kim SY; Kim JY; Cho EW Biochem Biophys Res Commun; 2014 Nov; 454(3):369-75. PubMed ID: 25451256 [TBL] [Abstract][Full Text] [Related]
43. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114 [TBL] [Abstract][Full Text] [Related]
44. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377 [TBL] [Abstract][Full Text] [Related]
45. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma]. Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438 [No Abstract] [Full Text] [Related]
46. Aberrant expression of the PRAC gene in prostate cancer. Lenka G; Weng WH; Chuang CK; Ng KF; Pang ST Int J Oncol; 2013 Dec; 43(6):1960-6. PubMed ID: 24100630 [TBL] [Abstract][Full Text] [Related]
47. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801 [TBL] [Abstract][Full Text] [Related]
48. ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer. Liu JW; Nagpal JK; Sun W; Lee J; Kim MS; Ostrow KL; Zhou S; Jeronimo C; Henrique R; Van Criekinge W; Moon CS; Califano JA; Trink B; Sidransky D Clin Cancer Res; 2008 Jun; 14(12):3754-60. PubMed ID: 18559593 [TBL] [Abstract][Full Text] [Related]
50. Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Chen Y; Hühn D; Knösel T; Pacyna-Gengelbach M; Deutschmann N; Petersen I Int J Cancer; 2005 Jan; 113(1):14-21. PubMed ID: 15386363 [TBL] [Abstract][Full Text] [Related]
51. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311 [TBL] [Abstract][Full Text] [Related]
52. Asporin is a stromally expressed marker associated with prostate cancer progression. Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543 [TBL] [Abstract][Full Text] [Related]
53. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Hudson RS; Yi M; Volfovsky N; Prueitt RL; Esposito D; Volinia S; Liu CG; Schetter AJ; Van Roosbroeck K; Stephens RM; Calin GA; Croce CM; Ambs S Mol Cancer; 2013 Feb; 12():13. PubMed ID: 23409773 [TBL] [Abstract][Full Text] [Related]
54. Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. Song EY; Shurin MR; Tourkova IL; Gutkin DW; Shurin GV Cancer Res; 2010 Jun; 70(11):4394-401. PubMed ID: 20460540 [TBL] [Abstract][Full Text] [Related]
55. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763 [TBL] [Abstract][Full Text] [Related]
56. Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma. Wu BJ; Zhou ZP; Li WP; Ding W; Wu YZ; Zhou ZW; Zhang RQ; Liu QF; Jiang H Tumour Biol; 2014 Jan; 35(1):123-7. PubMed ID: 23907575 [TBL] [Abstract][Full Text] [Related]
58. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884 [TBL] [Abstract][Full Text] [Related]
59. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation. Goto K; Ishikawa S; Honma R; Tanimoto K; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W Oncogene; 2016 Jul; 35(27):3598-606. PubMed ID: 26640143 [TBL] [Abstract][Full Text] [Related]
60. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Brandsma CA; van den Berge M; Postma DS; Jonker MR; Brouwer S; Paré PD; Sin DD; Bossé Y; Laviolette M; Karjalainen J; Fehrmann RS; Nickle DC; Hao K; Spanjer AI; Timens W; Franke L Thorax; 2015 Jan; 70(1):21-32. PubMed ID: 24990664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]